Malaysia · Delayed Price · Currency is MYR KLSE:SUNMED Statistics
Total Valuation
KLSE:SUNMED has a market cap or net worth of MYR 22.54 billion. The enterprise value is 23.57 billion.
| Market Cap | 22.54B |
| Enterprise Value | 23.57B |
Important Dates
The next estimated earnings date is Friday, June 12, 2026.
| Earnings Date | Jun 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KLSE:SUNMED has 11.50 billion shares outstanding. The number of shares has increased by 5.26% in one year.
| Current Share Class | 11.50B |
| Shares Outstanding | 11.50B |
| Shares Change (YoY) | +5.26% |
| Shares Change (QoQ) | -32.14% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 5.21% |
| Float | 2.29B |
Valuation Ratios
The trailing PE ratio is 89.50 and the forward PE ratio is 74.24. KLSE:SUNMED's PEG ratio is 4.11.
| PE Ratio | 89.50 |
| Forward PE | 74.24 |
| PS Ratio | 10.24 |
| PB Ratio | 8.94 |
| P/TBV Ratio | 9.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 48.41 |
| PEG Ratio | 4.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 48.45, with an EV/FCF ratio of -213.59.
| EV / Earnings | 93.46 |
| EV / Sales | 10.71 |
| EV / EBITDA | 48.45 |
| EV / EBIT | 79.21 |
| EV / FCF | -213.59 |
Financial Position
The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.64.
| Current Ratio | 1.13 |
| Quick Ratio | 1.01 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 3.32 |
| Debt / FCF | -14.65 |
| Interest Coverage | 5.03 |
Financial Efficiency
Return on equity (ROE) is 9.32% and return on invested capital (ROIC) is 7.81%.
| Return on Equity (ROE) | 9.32% |
| Return on Assets (ROA) | 3.91% |
| Return on Invested Capital (ROIC) | 7.81% |
| Return on Capital Employed (ROCE) | 7.62% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 9.37 |
Taxes
In the past 12 months, KLSE:SUNMED has paid 22.02 million in taxes.
| Income Tax | 22.02M |
| Effective Tax Rate | 8.03% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 64.57 |
| Average Volume (20 Days) | 119,024,775 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KLSE:SUNMED had revenue of MYR 2.20 billion and earned 252.21 million in profits. Earnings per share was 0.02.
| Revenue | 2.20B |
| Gross Profit | 1.38B |
| Operating Income | 297.58M |
| Pretax Income | 274.24M |
| Net Income | 252.21M |
| EBITDA | 477.42M |
| EBIT | 297.58M |
| Earnings Per Share (EPS) | 0.02 |
Balance Sheet
The company has 586.41 million in cash and 1.62 billion in debt, with a net cash position of -1.03 billion or -0.09 per share.
| Cash & Cash Equivalents | 586.41M |
| Total Debt | 1.62B |
| Net Cash | -1.03B |
| Net Cash Per Share | -0.09 |
| Equity (Book Value) | 2.52B |
| Book Value Per Share | 0.22 |
| Working Capital | 121.97M |
Cash Flow
In the last 12 months, operating cash flow was 465.66 million and capital expenditures -576.01 million, giving a free cash flow of -110.35 million.
| Operating Cash Flow | 465.66M |
| Capital Expenditures | -576.01M |
| Depreciation & Amortization | 179.84M |
| Net Borrowing | 515.36M |
| Free Cash Flow | -110.35M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 62.87%, with operating and profit margins of 13.52% and 11.46%.
| Gross Margin | 62.87% |
| Operating Margin | 13.52% |
| Pretax Margin | 12.46% |
| Profit Margin | 11.46% |
| EBITDA Margin | 21.70% |
| EBIT Margin | 13.52% |
| FCF Margin | n/a |
Dividends & Yields
KLSE:SUNMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 246.82% |
| Buyback Yield | -5.26% |
| Shareholder Yield | -5.26% |
| Earnings Yield | 1.12% |
| FCF Yield | -0.49% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KLSE:SUNMED has an Altman Z-Score of 0.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.79 |
| Piotroski F-Score | 6 |